From: Hemoglobin concentration is associated with the incidence of metabolic syndrome
MetS | Q1 (< 150 g/L) | Q2 (150–157 g/L) | Q3 (158–163 g/L) | Q4 (≥164 g/L) |
---|---|---|---|---|
n = 314 | n = 351 | n = 367 | n = 360 | |
Incidence, n (%) | 8 5 (24.9) | 90 (25.6) | 115 (31.3) | 121 (33.6) |
Model 1 | 1 (Ref) | 1.04 (0.74–1.45) | 1.37 (0.99–1.91) | 1.53 (1.10–2.12) * |
Model 2 | 1 (Ref) | 1.05 (0.74–1.49) | 1.35 (0.96–1.90) | 1.50 (1.06–2.11) * |
Model 3†| 1 (Ref) | 0.84 (0.57–1.25) | 1.03 (0.70–1.53) | 1.11 (0.75–1.65) |
WC | Q1 (< 151 g/L) | Q2 (151–157 g/L) | Q3 (158–164 g/L) | Q4 (≥165 g/L) |
n = 347 | n = 324 | n = 322 | n = 311 | |
Incidence, n (%) | 87 (25.1) | 96 (29.6) | 107 (33.2) | 109 (35.0) |
Model 1 | 1 (Ref) | 1.26 (0.90–1.77) | 1.49 (1.06–2.08) * | 1.61 (1.15–2.26) * |
Model 2 | 1 (Ref) | 1.28 (0.90–1.82) | 1.60 (1.13–2.26) * | 1.75 (1.23–2.49) * |
Model 3‡ | 1 (Ref) | 1.21 (0.83–1.75) | 1.58 (1.09–2.28) * | 1.65 (1.12–2.43) * |
BP | Q1 (< 150 g/L) | Q2 (150-156g/L) | Q3 (157-162g/L) | Q4 (≥163 g/L) |
n = 168 | n = 160 | n = 175 | n = 185 | |
Incidence, n (%) | 88 (52.4) | 68 (42.5) | 91 (52.0) | 105 (56.8) |
Model 1 | 1 (Ref) | 0.67 (0.44–1.04) | 0.99 (0.65–1.51) | 1.19 (0.78–1.82) |
Model 2 | 1 (Ref) | 0.67 (0.43–1.04) | 1.04 (0.67–1.61) | 1.28 (0.83–2.00) |
Model 3§ | 1 (Ref) | 0.76 (0.47–1.23) | 1.09 (0.67–1.74) | 1.24 (0.76–2.00) |
TGs | Q1 (< 150 g/L) | Q2 (150-156g/L) | Q3 (157-163g/L) | Q4 (≥164 g/L) |
n = 379 | n = 360 | n = 378 | n = 361 | |
Incidence, n (%) | 68 (17.9) | 60 (16.7) | 76 (20.1) | 79 (21.9) |
Model 1 | 1 (Ref) | 0.92 (0.62–1.34) | 1.15 (0.80–1.65) | 1.28 (0.89–1.84) |
Model 2 | 1 (Ref) | 0.90 (0.61–1.33) | 1.07 (0.74–1.57) | 1.20 (0.83–1.75) |
Model 3¶ | 1 (Ref) | 0.94 (0.60–1.45) | 0.96 (0.62–1.48) | 1.23 (0.80–1.89) |
HDL-c | Q1 (< 151 g/L) | Q2 (151-157g/L) | Q3 (158-164g/L) | Q4 (≥165 g/L) |
n = 384 | n = 395 | n = 415 | n = 406 | |
Incidence, n (%) | 36 (9.4) | 48 (12.2) | 54 (13.0) | 57 (14.0) |
Model 1 | 1 (Ref) | 1.33 (0.84–2.09) | 1.43 (0.92–2.24) | 1.57 (1.01–2.44) * |
Model 2 | 1 (Ref) | 1.19 (0.75–1.91) | 1.37 (0.87–2.16) | 1.51 (0.96–2.38) |
Model 3††| 1 (Ref) | 1.10 (0.66–1.82) | 1.18 (0.72–1.94) | 1.23 (0.75–2.03) |
FBG | Q1 (< 149 g/L) | Q2 (149-156g/L) | Q3 (157-163g/L) | Q4 (≥164 g/L) |
 | n = 149 | n = 134 | n = 141 | n = 137 |
Incidence, n (%) | 48 (38.1) | 43 (32.1) | 53 (37.6) | 42 (30.7) |
Model 1 | 1 (Ref) | 0.77 (0.46–1.28) | 0.98 (0.60–1.61) | 0.72 (0.43–1.20) |
Model 2 | 1 (Ref) | 0.85 (0.50–1.44) | 0.98 (0.58–1.66) | 0.74 (0.43–1.27) |
Model 3‡‡ | 1 (Ref) | 0.88 (0.47–1.66) | 1.00 (0.54–1.89) | 0.76 (0.39–1.49) |